Quilter Plc’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Quilter Plc’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-54,550	Closed	-$1.15M	–	331
2021 Q3	$1.15M	Buy	54,550 +42,695	+360%	+$940K	0.03%	121
2021 Q2	$234K	Sell	11,855 -145	-1%	-$3.39K	0.01%	275
2021 Q1	$349K	Hold	12,000	–	–	0.01%	233
2020 Q4	$363K	Hold	12,000	–	–	0.01%	191
2020 Q3	$191K	Sell	12,000 -1,000	-8%	-$18.2K	0.01%	242
2020 Q2	$257K	Hold	13,000	–	–	0.01%	201
2020 Q1	$160K	Hold	13,000	–	–	0.01%	209
2019 Q4	$240K	Buy	+13,000	New	+$190K	0.01%	175

Other funds holding NGM

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PIM

Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Quilter Plc's NGM Position: Q4 2021 in Review

Quilter Plc sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q4 2021, closing a stake of 54,550 shares — an estimated $1.15M sold.

Quilter Plc first reported a position in NGM in Q4 2019 and held it in 8 quarters. The position peaked at $1.15M in Q3 2021. 119 funds tracked by Wall St. Rank hold NGM as of Q4 2021.

Quilter Plc reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Quilter Plc sold 54,550 NGM Biopharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $1.15M.
Quilter Plc first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
Quilter Plc's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $1.15M in Q3 2021.
119 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Quilter Plc's 13F filing for Q4 2021, filed 14 Feb 2022.